speb/financial-data huggingface dataset:
Financial ratios for CQP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 48.74
Shares outstanding: 484054123
Market cap (USD): 23592797955.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CQP — quarterly report dated 2025-03-31
Total revenue: 2989000000
Gross profit: 1115000000
Operating income: 826000000
Net income: 641000000
Capital expenditures: 60000000
Operating cash flow: 665000000
Depreciation & amortization: 171000000
Net tangible assets: 0
Owner earnings: 752000000
Capex to operating income (%): 7.263922518159806
Buffett classification: The Great
Stock price: 61.4
P/E ratio: 11.591623694305772
Shares outstanding: 484054123
Book value: -380000000
Market cap (USD): 29720923152.2
Debt to equity: -38.99473684210526
Current ratio: 0.8834729626808835
Quick ratio: 0.7585681645087585
Interest coverage ratio: 4.347368421052631
COGS to revenue (%): 62.69655403144865
SG&A to revenue (%): 0.9033121445299431
Free cash flow (dilution-adjusted): 605000000
Buyback yield (%): 0
Inventory turnover: 11.426829268292684
Receivables turnover: 4.461194029850747
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.234142323046702
FCF margin (%): 20.24088323854132
Rule of 40 score: 20.24088323854132
Financial ratios for CQP — quarterly report dated 2025-06-30
Total revenue: 2455000000
Gross profit: 1088000000
Operating income: 715000000
Net income: 553000000
Capital expenditures: 68000000
Operating cash flow: 558000000
Depreciation & amortization: 171000000
Net tangible assets: 0
Owner earnings: 656000000
Capex to operating income (%): 9.51048951048951
Buffett classification: The Great
Stock price: 52.87
P/E ratio: 21.433786836691795
Shares outstanding: 484054123
Book value: -340000000
Market cap (USD): 25591941483.01
Debt to equity: -43.59411764705882
Current ratio: 0.6145015105740181
Quick ratio: 0.5220543806646526
Interest coverage ratio: 3.8031914893617023
COGS to revenue (%): 55.68228105906313
SG&A to revenue (%): 1.0590631364562118
Free cash flow (dilution-adjusted): 490000000
Buyback yield (%): 0
Inventory turnover: 8.934640522875817
Receivables turnover: 6.002444987775061
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.680851063829787
FCF margin (%): 19.95926680244399
Revenue growth (%): -17.865506858481098
Rule of 40 score: 2.093759943962894
Financial ratios for CQP — quarterly report dated 2025-09-30
Total revenue: 2404000000
Gross profit: 953000000
Operating income: 696000000
Net income: 506000000
Capital expenditures: 48000000
Operating cash flow: 658000000
Depreciation & amortization: 173000000
Net tangible assets: 0
Owner earnings: 631000000
Capex to operating income (%): 6.896551724137931
Buffett classification: The Great
Stock price: 51.53
P/E ratio: 14.672534681288235
Shares outstanding: 484054123
Book value: -348000000
Market cap (USD): 24943308958.190002
Debt to equity: -42.416666666666664
Current ratio: 0.6593989393046553
Quick ratio: 0.572775486152033
Interest coverage ratio: 3.6825396825396823
COGS to revenue (%): 60.35773710482529
SG&A to revenue (%): 1.0815307820299502
Free cash flow (dilution-adjusted): 610000000
Buyback yield (%): 0
Inventory turnover: 9.870748299319727
Receivables turnover: 4.224956063268893
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.598004888683358
FCF margin (%): 25.374376039933445
Revenue growth (%): -2.0773930753564156
Rule of 40 score: 23.29698296457703
Financial ratios for CQP — annual report dated 2025-12-31
Total revenue: 10758000000
Gross profit: 4925000000
Operating income: 3706000000
Net income: 2987000000
Capital expenditures: 199000000
Operating cash flow: 2768000000
Depreciation & amortization: 688000000
Net tangible assets: 414000000
Owner earnings: 3476000000
Return on net tangible assets (%): 839.6135265700483
Capex to operating income (%): 5.369670804101457
Buffett classification: The Great
Stock price: 52.05
P/E ratio: 8.434890225025109
Shares outstanding: 484054123
Book value: 414000000
P/B ratio: 60.85752923224637
Market cap (USD): 25195017102.149998
Debt to equity: 34.94444444444444
Current ratio: 0.7833723653395784
Quick ratio: 0.6779859484777517
Interest coverage ratio: 4.921646746347942
COGS to revenue (%): 54.22011526306005
SG&A to revenue (%): 0.9760178471834913
Free cash flow (dilution-adjusted): 2569000000
Buyback yield (%): 0
Inventory turnover: 32.40555555555556
Receivables turnover: 14.363150867823766
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.56157416237523
FCF margin (%): 23.87990332775609
Revenue growth (%): 23.598345588235293
Rule of 40 score: 47.47824891599139
Financial ratios for CQP — quarterly report dated 2025-12-31
Total revenue: 2910000000
Gross profit: 1769000000
Operating income: 1469000000
Net income: 1287000000
Capital expenditures: 23000000
Operating cash flow: 887000000
Depreciation & amortization: 173000000
Net tangible assets: 414000000
Owner earnings: 1437000000
Return on net tangible assets (%): 347.1014492753623
Capex to operating income (%): 1.5656909462219197
Buffett classification: The Great
Stock price: 52.05
P/E ratio: 8.434890225025109
Shares outstanding: 484054123
Book value: 414000000
P/B ratio: 60.85752923224637
Market cap (USD): 25195017102.149998
Debt to equity: 34.94444444444444
Current ratio: 0.7833723653395784
Quick ratio: 0.6779859484777517
Interest coverage ratio: 7.897849462365591
COGS to revenue (%): 39.20962199312715
SG&A to revenue (%): 0.8934707903780068
Free cash flow (dilution-adjusted): 864000000
Buyback yield (%): 0
Inventory turnover: 6.338888888888889
Receivables turnover: 3.885180240320427
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.339436709263145
FCF margin (%): 29.690721649484537
Revenue growth (%): 21.048252911813645
Rule of 40 score: 50.73897456129818
Financial ratios for CSC.AX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.151724137931035
Shares outstanding: 763791402
Market cap (USD): 6226216808.027587
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSC.AX — annual report dated 2024-12-31
Total revenue: 1178445454.5454545
Gross profit: 147939160.83916086
Operating income: 103669230.76923077
Net income: 60051748.25174826
Capital expenditures: 313309090.90909094
Operating cash flow: 278771328.67132866
Depreciation & amortization: 221086713.2867133
Net tangible assets: 2136087412.5874126
Owner earnings: -32170629.37062937
Return on net tangible assets (%): -1.5060539742454426
Capex to operating income (%): 302.2199437425378
Buffett classification: The Gruesome
Stock price: 6.093167701863354
P/E ratio: 77.49831165809303
Shares outstanding: 763791402
Book value: 2421544055.9440556
P/B ratio: 1.921876701026185
Market cap (USD): 4653909101.62733
Debt to equity: 0.3424313447352554
Current ratio: 0.7795880495170475
Quick ratio: 0.4778176075981466
Effective tax rate (%): 35.633441767730524
Interest coverage ratio: 4.143060756805097
COGS to revenue (%): 82.34559337090408
SG&A to revenue (%): 2.821424693073784
Free cash flow (dilution-adjusted): -45735664.33566434
Buyback yield (%): 0
Retained earnings: 177660139.86013988
Inventory turnover: 6.6253628585615525
Receivables turnover: 11.40443948160931
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.614139243952708
FCF margin (%): -3.881016652850117
Revenue growth (%): 9.358261513899075
Rule of 40 score: 5.477244861048958
Financial ratios for CSC.AX — quarterly report dated 2024-12-31
Total revenue: 331101398.6013986
Gross profit: 39888811.18881119
Operating income: 32716783.216783218
Net income: 32977622.37762238
Capital expenditures: 88707692.3076923
Operating cash flow: 116353846.15384616
Depreciation & amortization: 70352447.55244756
Net tangible assets: 2136087412.5874126
Owner earnings: 14622377.622377634
Return on net tangible assets (%): 0.6845402269687902
Capex to operating income (%): 271.1381853158063
Buffett classification: The Gruesome
Stock price: 6.093167701863354
P/E ratio: 35.28081139640719
Shares outstanding: 763791402
Book value: 2421544055.9440556
P/B ratio: 1.921876701026185
Market cap (USD): 4653909101.62733
Debt to equity: 0.3424313447352554
Current ratio: 0.7795880495170475
Quick ratio: 0.4778176075981466
Effective tax rate (%): 8.005930318754633
Interest coverage ratio: 1.482226587251299
COGS to revenue (%): 82.33613179154126
SG&A to revenue (%): 1.974761075030361
Free cash flow (dilution-adjusted): 27502797.202797204
Buyback yield (%): 0
Retained earnings: 177660139.86013988
Inventory turnover: 1.8612782170276154
Receivables turnover: 3.2042432240381684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8249914300345197
FCF margin (%): 8.306457574317546
Rule of 40 score: 8.306457574317546
Financial ratios for CSC.AX — quarterly report dated 2025-03-31
Total revenue: 375203496.5034965
Gross profit: 59342657.34265734
Operating income: 47699300.6993007
Net income: -818181.8181818182
Capital expenditures: 74858741.25874126
Operating cash flow: 85181118.88111888
Depreciation & amortization: 83967832.16783217
Net tangible assets: 2134073426.5734267
Owner earnings: 8290909.090909094
Capex to operating income (%): 156.93886526902213
Buffett classification: The Gruesome
Stock price: 5.352201257861635
Shares outstanding: 763791402
Book value: 2423456643.3566437
P/B ratio: 1.686832448079701
Market cap (USD): 4087965302.5283017
Debt to equity: 0.41920674480160824
Current ratio: 1.168807512192478
Quick ratio: 0.8576857186465388
Effective tax rate (%): 108.39190933868885
Interest coverage ratio: 2.476491304505682
COGS to revenue (%): 83.5842927194753
SG&A to revenue (%): 2.3494942604572624
Free cash flow (dilution-adjusted): 7411188.811188811
Buyback yield (%): 0
Retained earnings: 172915384.6153846
Inventory turnover: 2.0561273846802774
Receivables turnover: 2.4153716642057117
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1495541074945164
FCF margin (%): 1.975245135040938
Revenue growth (%): 13.319816252178057
Rule of 40 score: 15.295061387218995
Financial ratios for CSC.AX — quarterly report dated 2025-06-30
Total revenue: 412747445.25547445
Gross profit: 78147445.25547445
Operating income: 64997080.2919708
Net income: 21924087.591240875
Capital expenditures: 89049635.03649634
Operating cash flow: 172543065.69343063
Depreciation & amortization: 93883211.67883211
Net tangible assets: 2246045255.4744525
Owner earnings: 26757664.233576655
Return on net tangible assets (%): 1.191323468142871
Capex to operating income (%): 137.0055926150529
Buffett classification: The Gruesome
Stock price: 6.156862745098039
P/E ratio: 86.94992706278813
Shares outstanding: 763791402
Book value: 2552530656.9343066
P/B ratio: 1.8423123793733254
Market cap (USD): 4702558828
Debt to equity: 0.3862109651020441
Current ratio: 1.1101385936722106
Quick ratio: 0.7372414224856234
Effective tax rate (%): 43.5169340128251
Interest coverage ratio: 2.6997544189430918
COGS to revenue (%): 77.12232785818371
SG&A to revenue (%): 2.109064414357059
Free cash flow (dilution-adjusted): 80823357.66423358
Buyback yield (%): 0
Retained earnings: 197983941.6058394
Inventory turnover: 1.7432106167805892
Receivables turnover: 3.6085768985322275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.49887263891706
FCF margin (%): 19.581794773849442
Revenue growth (%): 10.006289680626164
Rule of 40 score: 29.588084454475606
Financial ratios for CSC.AX — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.611842105263158
P/E ratio: 121.62022671774793
Shares outstanding: 763791402
Market cap (USD): 6577650955.381578
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSC.AX — quarterly report dated 2025-12-31
Total revenue: 499975182.4817518
Gross profit: 169781021.8978102
Operating income: 155594160.58394158
Net income: 42628467.15328467
Capital expenditures: 115172992.70072992
Operating cash flow: 126712408.75912407
Depreciation & amortization: 82495620.4379562
Net tangible assets: 2474062043.7956204
Owner earnings: 9951094.890510947
Return on net tangible assets (%): 0.40221686903390347
Capex to operating income (%): 74.02141074477868
Buffett classification: The Good
Stock price: 10.174496644295303
P/E ratio: 121.93095655889773
Shares outstanding: 763791402
Book value: 2796791970.8029194
P/B ratio: 2.7786096133419624
Market cap (USD): 7771193056.590605
Debt to equity: 0.3476824985874066
Current ratio: 1.1970828564990967
Quick ratio: 0.8532542902351561
Effective tax rate (%): 57.352543833385674
Interest coverage ratio: 8.462918850246147
COGS to revenue (%): 66.04211011933438
SG&A to revenue (%): 1.9254970319694702
Free cash flow (dilution-adjusted): 6966423.357664233
Buyback yield (%): 0
Retained earnings: 416005839.41605836
Inventory turnover: 1.6748155306017425
Receivables turnover: 1.9392214983990013
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3248098595701285
FCF margin (%): 1.3933538307010858
Rule of 40 score: 1.3933538307010858
Financial ratios for CSC.AX — annual report dated 2025-12-31
Total revenue: 1733313138.6861312
Gross profit: 405868613.1386861
Operating income: 352007299.27007294
Net income: 255275912.40875912
Capital expenditures: 378902919.70802915
Operating cash flow: 500151824.81751823
Depreciation & amortization: 351486131.38686126
Net tangible assets: 2474062043.7956204
Owner earnings: 227859124.0875913
Return on net tangible assets (%): 9.209919559576512
Capex to operating income (%): 107.64064282011405
Buffett classification: The Gruesome
Stock price: 10.174496644295303
P/E ratio: 30.442328002130594
Shares outstanding: 763791402
Book value: 2796791970.8029194
P/B ratio: 2.7786096133419624
Market cap (USD): 7771193056.590605
Debt to equity: 0.3476824985874066
Current ratio: 1.1970828564990967
Quick ratio: 0.8532542902351561
Effective tax rate (%): 27.948032790600415
Interest coverage ratio: 4.2383308578610155
COGS to revenue (%): 75.96312534242047
SG&A to revenue (%): 2.2836313224873335
Free cash flow (dilution-adjusted): 105552554.74452554
Buyback yield (%): 0
Retained earnings: 416005839.41605836
Inventory turnover: 6.67847715097057
Receivables turnover: 6.722889894880485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.521859013612497
FCF margin (%): 6.089641414968759
Revenue growth (%): 47.08471503712475
Rule of 40 score: 53.17435645209351
Financial ratios for CXSE3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.0140350877192983
Shares outstanding: 3000000000
Market cap (USD): 3042105263.157895
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXSE3.SA — annual report dated 2022-12-31
Total revenue: 319591098.4848485
Net income: 569879356.060606
Capital expenditures: 0
Operating cash flow: 457635227.27272725
Net tangible assets: 2334729166.6666665
Owner earnings: 569879356.060606
Return on net tangible assets (%): 24.40879928159859
Buffett classification: The Gruesome
Stock price: 1.1821631878557877
P/E ratio: 6.223228698935706
Shares outstanding: 3000000000
Book value: 2334729166.666667
P/B ratio: 1.5190154019580555
Market cap (USD): 3546489563.567363
Debt to equity: 0
Effective tax rate (%): 14.766323514516442
COGS to revenue (%): 0
SG&A to revenue (%): 1.1851081015573286
Free cash flow (dilution-adjusted): 457635227.27272725
Buyback yield (%): 0
Retained earnings: 289990530.3030303
Receivables turnover: 15.770771416288156
Capitalized R&D asset: 0
FCF margin (%): 143.1939842637461
Rule of 40 score: 143.1939842637461
Financial ratios for CXSE3.SA — annual report dated 2023-12-31
Total revenue: 411211958.76288664
Net income: 738607010.3092784
Capital expenditures: 0
Operating cash flow: 582977731.9587629
Net tangible assets: 2595026804.1237116
Owner earnings: 738607010.3092784
Return on net tangible assets (%): 28.462403900243764
Buffett classification: The Gruesome
Stock price: 2.1946169772256727
P/E ratio: 8.913875497769984
Shares outstanding: 3000000000
Book value: 2595026804.1237116
P/B ratio: 2.537103247340157
Market cap (USD): 6583850931.677018
Debt to equity: 0
Effective tax rate (%): 11.87799746918646
COGS to revenue (%): 0
SG&A to revenue (%): 1.0292933435888283
Free cash flow (dilution-adjusted): 582977731.9587629
Buyback yield (%): 0
Retained earnings: 0
Receivables turnover: 12.966925652612074
Capitalized R&D asset: 0
FCF margin (%): 141.77061720496314
Revenue growth (%): 28.668151494958423
Rule of 40 score: 170.43876869992158
Financial ratios for CXSE3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.3259668508287294
Shares outstanding: 3000000000
Market cap (USD): 6977900552.486188
Buyback yield (%): 0
Retained earnings: 203392633.5174954
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXSE3.SA — annual report dated 2024-12-31
Total revenue: 376430582.52427185
Net income: 609253074.4336569
Capital expenditures: 0
Operating cash flow: 582477669.9029126
Net tangible assets: 2085651132.6860843
Owner earnings: 609253074.4336569
Return on net tangible assets (%): 29.211648337802664
Buffett classification: The Gruesome
Stock price: 2.0290791599353795
P/E ratio: 9.991311878835653
Shares outstanding: 3000000000
Book value: 2085651132.6860843
P/B ratio: 2.9186268903785746
Market cap (USD): 6087237479.806138
Debt to equity: 0
Effective tax rate (%): 13.174888130215159
COGS to revenue (%): 0
SG&A to revenue (%): 1.1227072901178288
Free cash flow (dilution-adjusted): 582477669.9029126
Buyback yield (%): 0
Receivables turnover: 15.04534283607766
Capitalized R&D asset: 0
FCF margin (%): 154.73707422944443
Revenue growth (%): -8.45825990646115
Rule of 40 score: 146.2788143229833
Financial ratios for CXSE3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.0290791599353795
Shares outstanding: 3000000000
Market cap (USD): 6087237479.806138
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXSE3.SA — quarterly report dated 2025-03-31
Total revenue: 106838194.44444445
Net income: 182364409.72222224
Capital expenditures: 0
Operating cash flow: 161510243.05555555
Net tangible assets: 2436216493.055556
Owner earnings: 182364409.72222224
Return on net tangible assets (%): 7.485558456814189
Buffett classification: The Gruesome
Stock price: 2.3333333333333335
P/E ratio: 9.596170670941786
Shares outstanding: 3000000000
Book value: 2436216493.0555553
P/B ratio: 2.873307860756024
Market cap (USD): 7000000000
Debt to equity: 0
Effective tax rate (%): 11.08422128996651
COGS to revenue (%): 0
SG&A to revenue (%): 0.9956320240238677
Free cash flow (dilution-adjusted): 161510243.05555555
Buyback yield (%): 0
Retained earnings: 182364409.72222224
Receivables turnover: 3.528054716299655
Capitalized R&D asset: 0
FCF margin (%): 151.17275604984172
Rule of 40 score: 151.17275604984172
Financial ratios for CXSE3.SA — quarterly report dated 2025-06-30
Total revenue: 106767153.28467153
Net income: 187665693.4306569
Capital expenditures: 0
Operating cash flow: 158538868.61313868
Net tangible assets: 2432612408.759124
Owner earnings: 187665693.4306569
Return on net tangible assets (%): 7.714574370949018
Buffett classification: The Gruesome
Stock price: 2.463503649635036
P/E ratio: 19.97272893727702
Shares outstanding: 3000000000
Book value: 2432612408.759124
P/B ratio: 3.038096378319064
Market cap (USD): 7390510948.905108
Debt to equity: 0
Effective tax rate (%): 11.191325763986999
COGS to revenue (%): 0
SG&A to revenue (%): 1.3444223393564
Free cash flow (dilution-adjusted): 158538868.61313868
Buyback yield (%): 0
Retained earnings: 209639963.50364962
Receivables turnover: 4.244075468413379
Capitalized R&D asset: 0
FCF margin (%): 148.49030224719868
Revenue growth (%): -0.06649415982957184
Rule of 40 score: 148.4238080873691
Financial ratios for CXSE3.SA — quarterly report dated 2025-09-30
Total revenue: 119398308.27067669
Net income: 214427443.60902256
Capital expenditures: 0
Operating cash flow: 173153007.51879698
Net tangible assets: 2538659586.466165
Owner earnings: 214427443.60902256
Return on net tangible assets (%): 8.446482732547349
Buffett classification: The Gruesome
Stock price: 2.6710526315789473
P/E ratio: 13.71041907001206
Shares outstanding: 3000000000
Book value: 2538659586.466165
P/B ratio: 3.1564523016223784
Market cap (USD): 8013157894.736842
Debt to equity: 0
Effective tax rate (%): 11.135744688806765
COGS to revenue (%): 0
SG&A to revenue (%): 1.7953428767992397
Free cash flow (dilution-adjusted): 173153007.51879698
Buyback yield (%): 0
Retained earnings: 249921240.60150376
Receivables turnover: 3.9839875061152297
Capitalized R&D asset: 0
FCF margin (%): 145.0213240260139
Revenue growth (%): 11.830562675326666
Rule of 40 score: 156.85188670134056
Financial ratios for CXSE3.SA — annual report dated 2025-12-31
Total revenue: 448558941.6058394
Net income: 783131386.8613138
Capital expenditures: 0
Operating cash flow: 700808941.6058394
Net tangible assets: 2472716058.3941603
Owner earnings: 783131386.8613138
Return on net tangible assets (%): 31.670898249833733
Buffett classification: The Gruesome
Stock price: 2.867145421903052
P/E ratio: 10.983388496510866
Shares outstanding: 3000000000
Book value: 2472716058.3941603
P/B ratio: 3.4785377951139
Market cap (USD): 8601436265.709156
Debt to equity: 0
Effective tax rate (%): 11.143944383491702
COGS to revenue (%): 0
SG&A to revenue (%): 1.486064660431235
Free cash flow (dilution-adjusted): 700808941.6058394
Buyback yield (%): 0
Receivables turnover: 15.10429391306485
Capitalized R&D asset: 0
FCF margin (%): 156.2356418750557
Revenue growth (%): 19.16113154194021
Rule of 40 score: 175.39677341699593
Financial ratios for CXSE3.SA — quarterly report dated 2025-12-31
Total revenue: 113582481.75182481
Net income: 195616605.83941606
Capital expenditures: 0
Operating cash flow: 204410036.49635035
Net tangible assets: 2472716058.3941603
Owner earnings: 195616605.83941606
Return on net tangible assets (%): 7.911001555368798
Buffett classification: The Gruesome
Stock price: 2.867145421903052
P/E ratio: 11.026434137095682
Shares outstanding: 3000000000
Book value: 2472716058.3941603
P/B ratio: 3.4785377951139
Market cap (USD): 8601436265.709156
Debt to equity: 0
Effective tax rate (%): 11.16566684649342
COGS to revenue (%): 0
SG&A to revenue (%): 1.7884684592051823
Free cash flow (dilution-adjusted): 204410036.49635035
Buyback yield (%): 0
Receivables turnover: 3.824654975359772
Capitalized R&D asset: 0
FCF margin (%): 179.96616497866432
Revenue growth (%): -4.870945495866962
Rule of 40 score: 175.09521948279738
Financial ratios for CZZ.V — annual report dated 2022-03-31
Total revenue: 0
Operating income: -84095.2
Net income: -84095.2
Capital expenditures: 0
Operating cash flow: -84546.4
Net tangible assets: 106727.2
Owner earnings: -84095.2
Return on net tangible assets (%): -78.79453410189717
Buffett classification: The Gruesome
Stock price: 0.064
Shares outstanding: 38703854
Book value: 106727.2
P/B ratio: 23.20914121236199
Market cap (USD): 2477046.656
Debt to equity: 0
Free cash flow (dilution-adjusted): -84546.4
Buyback yield (%): 0
Retained earnings: -2193339.2
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -78.79453410189717
Rule of 40 score: 0
Financial ratios for CZZ.V — annual report dated 2023-03-31
Total revenue: 0
Operating income: -127920.74074074073
Net income: -127920.74074074073
Capital expenditures: 0
Operating cash flow: -71385.92592592593
Net tangible assets: 25122.96296296296
Owner earnings: -127920.74074074073
Return on net tangible assets (%): -509.17855879231047
Buffett classification: The Gruesome
Stock price: 0.05185185185185185
Shares outstanding: 38703854
Book value: 25122.962962962964
P/B ratio: 79.88176023115933
Market cap (USD): 2006866.5037037036
Debt to equity: 0
Current ratio: 10.198806617846488
Quick ratio: 10.198806617846488
Free cash flow (dilution-adjusted): -125608.14814814815
Buyback yield (%): 0
Retained earnings: -2158790.3703703703
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -509.17855879231035
Rule of 40 score: 0
Financial ratios for CZZ.V — annual report dated 2024-03-31
Total revenue: 0
Operating income: -103706.66666666666
Net income: -103706.66666666666
Capital expenditures: 0
Operating cash flow: -88617.77777777777
Net tangible assets: 92365.92592592593
Owner earnings: -103706.66666666666
Return on net tangible assets (%): -112.27805668275938
Buffett classification: The Gruesome
Stock price: 0.05147058823529412
Shares outstanding: 38703854
Book value: 92365.92592592593
P/B ratio: 21.567586882099146
Market cap (USD): 1992110.1323529414
Debt to equity: 0
Current ratio: 6.202954185095552
Quick ratio: 6.202954185095552
Free cash flow (dilution-adjusted): -88617.77777777777
Buyback yield (%): 0
Retained earnings: -2284140
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -112.27805668275938
Rule of 40 score: 0
Financial ratios for CZZ.V — quarterly report dated 2024-09-30
Total revenue: 0
Operating income: -15745.925925925925
Net income: -15745.925925925925
Capital expenditures: 0
Operating cash flow: -32517.037037037036
Net tangible assets: 37716.29629629629
Owner earnings: -15745.925925925925
Return on net tangible assets (%): -41.748335526445004
Buffett classification: The Gruesome
Stock price: 0.037037037037037035
Shares outstanding: 38703854
Book value: 37716.29629629629
P/B ratio: 38.00680912072589
Market cap (USD): 1433476.074074074
Debt to equity: 0
Free cash flow (dilution-adjusted): -32517.037037037036
Buyback yield (%): 0
Retained earnings: -2338789.6296296297
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.748335526445004
Rule of 40 score: 0
Financial ratios for CZZ.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -59984.61538461539
Net income: -59984.61538461539
Capital expenditures: 0
Operating cash flow: -19496.503496503497
Net tangible assets: 2195.104895104895
Owner earnings: -59984.61538461539
Return on net tangible assets (%): -2732.6537113730487
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 38703854
Book value: 2195.1048951048942
P/B ratio: 493.19979611341216
Market cap (USD): 1082625.2867132868
Debt to equity: 0
Current ratio: 1.1517158047365876
Quick ratio: 1.1517158047365876
Free cash flow (dilution-adjusted): -46069.93006993007
Buyback yield (%): 0
Retained earnings: -2267932.867132867
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2732.65371137305
Rule of 40 score: 0
Financial ratios for CZZ.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -12211.888111888113
Net income: -12211.888111888113
Capital expenditures: 0
Operating cash flow: -25409.79020979021
Net tangible assets: 128011.88811188811
Owner earnings: -12211.888111888113
Return on net tangible assets (%): -9.539651583932875
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 38703854
Book value: 128011.88811188813
P/B ratio: 8.457224580321975
Market cap (USD): 1082625.2867132868
Debt to equity: 0
Current ratio: 260.6553191489362
Quick ratio: 260.6553191489362
Free cash flow (dilution-adjusted): -25409.79020979021
Buyback yield (%): 0
Retained earnings: -2288969.230769231
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.539651583932873
Rule of 40 score: 0
Financial ratios for CZZ.V — annual report dated 2025-03-31
Total revenue: 0
Operating income: -123788.81118881119
Net income: -123788.81118881119
Capital expenditures: 0
Operating cash flow: -114831.46853146853
Net tangible assets: 128011.88811188811
Owner earnings: -123788.81118881119
Return on net tangible assets (%): -96.70102754879628
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 38703854
Book value: 128011.88811188813
P/B ratio: 8.457224580321975
Market cap (USD): 1082625.2867132868
Debt to equity: 0
Current ratio: 260.6553191489362
Quick ratio: 260.6553191489362
Free cash flow (dilution-adjusted): -141404.8951048951
Buyback yield (%): 0
Retained earnings: -2288969.230769231
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -96.70102754879628
Rule of 40 score: 0
Financial ratios for CZZ.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -32513.138686131384
Net income: -32513.138686131384
Capital expenditures: 0
Operating cash flow: -23740.875912408756
Net tangible assets: 101105.10948905109
Owner earnings: -32513.138686131384
Return on net tangible assets (%): -32.15776022640311
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 38703854
Book value: 101105.10948905109
P/B ratio: 11.176878582670344
Market cap (USD): 1130039.5328467153
Debt to equity: 0
Current ratio: 18.28400299475917
Quick ratio: 18.28400299475917
Free cash flow (dilution-adjusted): -23740.875912408756
Buyback yield (%): 0
Retained earnings: -2421729.197080292
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.15776022640311
Rule of 40 score: 0
Financial ratios for CZZ.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -140781.7518248175
Net income: -140781.7518248175
Capital expenditures: 0
Operating cash flow: -25963.503649635033
Net tangible assets: 60883.94160583941
Owner earnings: -140781.7518248175
Return on net tangible assets (%): -231.22969392526164
Buffett classification: The Gruesome
Stock price: 0.051094890510948905
Shares outstanding: 38703854
Book value: 60883.94160583941
P/B ratio: 32.48096510052631
Market cap (USD): 1977569.1824817518
Debt to equity: 0
Current ratio: 85.9399185336049
Quick ratio: 85.9399185336049
Free cash flow (dilution-adjusted): -25963.503649635033
Buyback yield (%): 0
Retained earnings: -2573581.02189781
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -231.22969392526164
Rule of 40 score: 0
Financial ratios for DML.TO — annual report dated 2021-12-31
Gross profit: 5810236.220472441
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.3700787401574803
Shares outstanding: 905016962
Market cap (USD): 1239944499.1181102
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DML.TO — annual report dated 2022-12-31
Total revenue: 6597794.117647058
Gross profit: 2808823.5294117643
Operating income: -26847794.117647056
Net income: 10554411.764705881
Capital expenditures: 5041911.764705882
Operating cash flow: -20694117.647058822
Depreciation & amortization: 6372794.117647058
Net tangible assets: 320600000
Owner earnings: 11885294.11764706
Return on net tangible assets (%): 3.7072034053796195
Buffett classification: The Gruesome
Stock price: 1.1397058823529411
P/E ratio: 97.72720434025359
Shares outstanding: 905016962
Book value: 320599999.99999994
P/B ratio: 3.2172587499082606
Market cap (USD): 1031453155.2205882
Debt to equity: 0
Current ratio: 3.647026880260657
Quick ratio: 3.499701330437144
Effective tax rate (%): -22.022711831505386
Interest coverage ratio: -608.55
COGS to revenue (%): 57.42783907277388
SG&A to revenue (%): 139.7303020171626
Free cash flow (dilution-adjusted): -28491911.76470588
Buyback yield (%): 0
Retained earnings: -864158823.5294117
Inventory turnover: 1.8993733873940288
Receivables turnover: 2.165821868211441
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.341052432642179
FCF margin (%): -431.8399643374568
Rule of 40 score: -431.8399643374568
Financial ratios for DML.TO — annual report dated 2023-12-31
Total revenue: 1405303.0303030303
Gross profit: -1405303.0303030303
Operating income: -37044696.96969697
Net income: 68465909.0909091
Capital expenditures: 2355303.0303030303
Operating cash flow: -23232575.757575758
Depreciation & amortization: 7114393.939393939
Net tangible assets: 486200000
Owner earnings: 73225000
Return on net tangible assets (%): 15.06067461949815
Buffett classification: The Gruesome
Stock price: 1.7575757575757573
P/E ratio: 23.232523948437063
Shares outstanding: 905016962
Book value: 486199999.99999994
P/B ratio: 3.2715669942535186
Market cap (USD): 1590635872.6060605
Debt to equity: 0
Current ratio: 8.277109105093057
Quick ratio: 8.077621754151341
Effective tax rate (%): -2.6924535456958667
Interest coverage ratio: -940.3653846153846
COGS to revenue (%): 200
SG&A to revenue (%): 741.7789757412398
Free cash flow (dilution-adjusted): -28520454.545454547
Buyback yield (%): 0
Retained earnings: -821879545.4545454
Inventory turnover: 1.0363128491620113
Receivables turnover: 0.9696811291165709
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.900235233688513
FCF margin (%): -2029.4878706199463
Revenue growth (%): -78.70041099730167
Rule of 40 score: -2108.188281617248
Financial ratios for DML.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.822222222222222
Shares outstanding: 905016962
Market cap (USD): 1649142019.6444442
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DML.TO — annual report dated 2024-12-31
Total revenue: 2813286.713286713
Gross profit: -553846.1538461539
Operating income: -44281818.18181819
Net income: -63719580.41958042
Capital expenditures: 5209790.20979021
Operating cash flow: -28240559.440559443
Depreciation & amortization: 6943356.643356644
Net tangible assets: 394630769.2307693
Owner earnings: -61986013.986013986
Return on net tangible assets (%): -15.70734438848742
Buffett classification: The Gruesome
Stock price: 1.8251748251748252
Shares outstanding: 905016962
Book value: 394630769.2307692
P/B ratio: 4.185720689287322
Market cap (USD): 1651814175.3986015
Debt to equity: 0
Current ratio: 3.6506447139358533
Quick ratio: 3.5401138945442745
Interest coverage ratio: -586.3240740740741
COGS to revenue (%): 119.6868008948546
SG&A to revenue (%): 410.01739995028584
Free cash flow (dilution-adjusted): -36874825.17482518
Buyback yield (%): 0
Retained earnings: -822377622.3776224
Inventory turnover: 1.285371062466631
Receivables turnover: 1.308292682926829
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.055707121555226
FCF margin (%): -1310.7382550335572
Revenue growth (%): 100.19075264358284
Rule of 40 score: -1210.5475023899744
Financial ratios for DML.TO — quarterly report dated 2024-12-31
Gross profit: -19580.41958041958
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8251748251748252
Shares outstanding: 905016962
Market cap (USD): 1651814175.3986015
Buyback yield (%): 0
Inventory turnover: 0.3198077949813134
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DML.TO — quarterly report dated 2025-03-31
Total revenue: 961538.4615384616
Gross profit: 961538.4615384616
Operating income: -15479720.27972028
Net income: -30443356.643356644
Capital expenditures: 4256643.356643356
Operating cash flow: -11801398.601398602
Depreciation & amortization: 1753846.153846154
Net tangible assets: 365176223.7762238
Owner earnings: -32946153.846153848
Return on net tangible assets (%): -9.021987659947683
Buffett classification: The Gruesome
Stock price: 1.3146853146853146
Shares outstanding: 905016962
Book value: 365176223.7762238
P/B ratio: 3.2581872313012967
Market cap (USD): 1189812509.4825175
Debt to equity: 0
Current ratio: 3.2104122857324917
Quick ratio: 3.0903268973427642
Interest coverage ratio: -32.55294117647059
COGS to revenue (%): 0
SG&A to revenue (%): 344.9454545454546
Free cash flow (dilution-adjusted): -17027972.027972028
Buyback yield (%): 0
Retained earnings: -852820979.020979
Inventory turnover: 0
Receivables turnover: 0.36165176223040507
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.771052030841673
FCF margin (%): -1770.9090909090908
Rule of 40 score: -1770.9090909090908
Financial ratios for DML.TO — quarterly report dated 2025-06-30
Total revenue: 931386.8613138685
Gross profit: -80291.9708029197
Operating income: -13715328.467153283
Net income: 9122627.737226278
Capital expenditures: 3818978.1021897807
Operating cash flow: -16764963.503649633
Depreciation & amortization: 1988321.1678832115
Net tangible assets: 391135036.49635035
Owner earnings: 7291970.802919708
Return on net tangible assets (%): 1.8643103078258112
Buffett classification: The Gruesome
Stock price: 1.8175182481751826
P/E ratio: 45.07705703672588
Shares outstanding: 905016962
Book value: 391135036.4963503
P/B ratio: 4.205414217241605
Market cap (USD): 1644884843.3430657
Debt to equity: 0
Current ratio: 3.9446606300980314
Quick ratio: 3.7911771308837827
Effective tax rate (%): -0.6685461135722915
Interest coverage ratio: -347.96296296296293
COGS to revenue (%): 108.62068965517241
SG&A to revenue (%): 360.7366771159875
Free cash flow (dilution-adjusted): -21386131.38686131
Buyback yield (%): 0
Retained earnings: -881048175.1824816
Inventory turnover: 0.33788395904436863
Receivables turnover: 0.3100850546780073
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.1308474282562733
FCF margin (%): -2296.1598746081504
Revenue growth (%): -3.135766423357679
Rule of 40 score: -2299.2956410315082
Financial ratios for DML.TO — quarterly report dated 2025-09-30
Total revenue: 751798.5611510791
Gross profit: -117985.61151079138
Operating income: -15901438.848920865
Net income: -97097122.30215828
Capital expenditures: 5592086.330935252
Operating cash flow: -14294964.02877698
Depreciation & amortization: 3951079.136690648
Net tangible assets: 289857553.95683455
Owner earnings: -98738129.49640289
Return on net tangible assets (%): -34.064363046100546
Buffett classification: The Gruesome
Stock price: 2.7553956834532376
Shares outstanding: 905016962
Book value: 289857553.9568345
P/B ratio: 8.60312176276117
Market cap (USD): 2493679830.546763
Debt to equity: 0.7317610734123933
Current ratio: 11.97288817569995
Quick ratio: 11.782195291356311
Interest coverage ratio: -4.410896028736779
COGS to revenue (%): 115.69377990430623
SG&A to revenue (%): 350.622009569378
Free cash flow (dilution-adjusted): -20700719.424460433
Buyback yield (%): 0
Retained earnings: -965468345.3237411
Inventory turnover: 0.15184626978146196
Receivables turnover: 0.14560401281872648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.0745770220626194
FCF margin (%): -2753.4928229665074
Revenue growth (%): -19.281815926569084
Rule of 40 score: -2772.7746388930764
Financial ratios for DML.TO — quarterly report dated 2025-12-31
Total revenue: 891970.802919708
Operating income: -16758394.16058394
Net income: -37435766.42335766
Capital expenditures: 22882481.751824815
Operating cash flow: -6156204.379562044
Depreciation & amortization: 5145255.474452554
Net tangible assets: 268883211.6788321
Owner earnings: -55172992.70072992
Return on net tangible assets (%): -20.51931481933925
Buffett classification: The Gruesome
Stock price: 2.656934306569343
Shares outstanding: 905016962
Book value: 268883211.67883205
P/B ratio: 8.942806802074003
Market cap (USD): 2404570614.3649635
Debt to equity: 0.8027798137741945
Current ratio: 10.748700140058709
Quick ratio: 10.51334394965561
Interest coverage ratio: -2.2438428459734165
COGS to revenue (%): 0
SG&A to revenue (%): 536.3338788870703
Free cash flow (dilution-adjusted): -29903649.635036495
Buyback yield (%): 0
Retained earnings: -1016998540.1459854
Inventory turnover: 0
Receivables turnover: 0.22918229557389347
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1783703827400274
FCF margin (%): -3352.53682487725
Revenue growth (%): 18.64492019697551
Rule of 40 score: -3333.891904680275
Financial ratios for DML.TO — annual report dated 2025-12-31
Total revenue: 3589781.02189781
Operating income: -62764963.50364963
Net income: -158604379.5620438
Capital expenditures: 36818248.17518248
Operating cash flow: -49743065.693430655
Depreciation & amortization: 12972992.700729925
Net tangible assets: 268883211.6788321
Owner earnings: -182449635.03649634
Return on net tangible assets (%): -67.85460270923255
Buffett classification: The Gruesome
Stock price: 2.656934306569343
Shares outstanding: 905016962
Book value: 268883211.67883205
P/B ratio: 8.942806802074003
Market cap (USD): 2404570614.3649635
Debt to equity: 0.8027798137741945
Current ratio: 10.748700140058709
Quick ratio: 10.51334394965561
Interest coverage ratio: -5.641146755887949
COGS to revenue (%): 0
SG&A to revenue (%): 397.80398535990236
Free cash flow (dilution-adjusted): -90066423.35766423
Buyback yield (%): 0
Retained earnings: -1016998540.1459854
Inventory turnover: 0
Receivables turnover: 0.9223555888972244
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.158618078794785
FCF margin (%): -2508.9670597803984
Revenue growth (%): 27.600965978470505
Rule of 40 score: -2481.366093801928
Financial ratios for EPSN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.66
Shares outstanding: 30248617
Market cap (USD): 140958555.22
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPSN — annual report dated 2022-12-31
Total revenue: 69962709
Gross profit: 54107804
Operating income: 46751821
Net income: 35354679
Capital expenditures: 7870003
Operating cash flow: 38005360
Depreciation & amortization: 6438511
Net tangible assets: 104245205
Owner earnings: 33923187
Return on net tangible assets (%): 32.541724101362746
Capex to operating income (%): 16.833575316777498
Buffett classification: The Great
Stock price: 5.65
P/E ratio: 4.834004745171071
Shares outstanding: 30248617
Book value: 104245205
P/B ratio: 1.6394488940762313
Market cap (USD): 170904686.05
Debt to equity: 0.0003386150950540123
Current ratio: 8.917842328054748
Quick ratio: 8.917842328054748
Effective tax rate (%): 25.58815567364367
Interest coverage ratio: 920.637647197826
COGS to revenue (%): 22.66193694700987
SG&A to revenue (%): 10.500505347784632
Free cash flow (dilution-adjusted): 28914331
Buyback yield (%): 3.6481615244744776
Retained earnings: -39290540
Receivables turnover: 9.715172745913078
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.74047429458433
FCF margin (%): 41.32820385785805
Rule of 40 score: 41.32820385785805
Financial ratios for EPSN — annual report dated 2023-12-31
Total revenue: 30729752
Gross profit: 14179693
Operating income: 6868197
Net income: 6945153
Capital expenditures: 18633577
Operating cash flow: 18188299
Depreciation & amortization: 7685084
Net tangible assets: 100612965
Owner earnings: -4003340
Return on net tangible assets (%): -3.9789504265180935
Capex to operating income (%): 271.30230830594985
Buffett classification: The Gruesome
Stock price: 4.55
P/E ratio: 19.81687190332596
Shares outstanding: 30248617
Book value: 100612965
P/B ratio: 1.367927158791116
Market cap (USD): 137631207.35
Debt to equity: 0.005599516921104552
Current ratio: 5.208918314221586
Quick ratio: 5.208918314221586
Effective tax rate (%): 31.54517229143668
Interest coverage ratio: 85.44765423804725
COGS to revenue (%): 53.85679324714368
SG&A to revenue (%): 23.792889705064983
Free cash flow (dilution-adjusted): -1476038
Buyback yield (%): 4.399874938683374
Retained earnings: -37946042
Receivables turnover: 5.108472718906389
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.913377479947333
FCF margin (%): -4.803286404654355
Revenue growth (%): -56.07695522481841
Rule of 40 score: -60.88024162947277
Financial ratios for EPSN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.44
Shares outstanding: 30248617
Market cap (USD): 164552476.48000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPSN — quarterly report dated 2024-12-31
Capital expenditures: 4641567
Buffett classification: The Gruesome
Stock price: 5.83
Shares outstanding: 30248617
Market cap (USD): 176349437.11
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPSN — annual report dated 2024-12-31
Total revenue: 31522775
Gross profit: 11807642
Operating income: 4874512
Net income: 1927800
Capital expenditures: 36560896
Operating cash flow: 16830279
Depreciation & amortization: 10185119
Net tangible assets: 96728129
Owner earnings: -24447977
Return on net tangible assets (%): -25.2749404467443
Capex to operating income (%): 750.0421785811585
Buffett classification: The Gruesome
Stock price: 5.83
P/E ratio: 91.47703968772693
Shares outstanding: 30248617
Book value: 96728129
P/B ratio: 1.8231453345903135
Market cap (USD): 176349437.11
Debt to equity: 0.004930427218332736
Current ratio: 2.024570892264148
Quick ratio: 2.024570892264148
Effective tax rate (%): 45.80101228797155
Interest coverage ratio: 105.05413793103449
COGS to revenue (%): 62.54250458596998
SG&A to revenue (%): 21.994034471901664
Free cash flow (dilution-adjusted): -20975033
Buyback yield (%): 1.0383974170883021
Retained earnings: -41505076
Receivables turnover: 5.394297504227614
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.295678815956794
FCF margin (%): -66.53929738102055
Revenue growth (%): 2.5806358606473623
Rule of 40 score: -63.958661520373184
Financial ratios for EPSN — quarterly report dated 2025-03-31
Total revenue: 16163140
Gross profit: 9378734
Operating income: 7174478
Net income: 4016034
Capital expenditures: 7744042
Operating cash flow: 8582576
Depreciation & amortization: 3475857
Net tangible assets: 99704273
Owner earnings: -252151
Return on net tangible assets (%): -0.2528988903013214
Capex to operating income (%): 107.93875178096582
Buffett classification: The Gruesome
Stock price: 6.69
P/E ratio: 12.59720707855063
Shares outstanding: 30248617
Book value: 99704273
P/B ratio: 2.0296346549761215
Market cap (USD): 202363247.73000002
Debt to equity: 0.004491482526531235
Current ratio: 1.6639538489849361
Quick ratio: 1.6639538489849361
Effective tax rate (%): 29.372617489133397
Interest coverage ratio: 587.5422160347227
COGS to revenue (%): 41.97455444919737
SG&A to revenue (%): 13.637548149678839
Free cash flow (dilution-adjusted): 452696
Buyback yield (%): 0
Retained earnings: -38864654
Receivables turnover: 2.01950467525714
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.176165456626933
FCF margin (%): 2.8007924202846723
Rule of 40 score: 2.8007924202846723
Financial ratios for EPSN — quarterly report dated 2025-06-30
Total revenue: 11624733
Gross profit: 5346499
Operating income: 3498783
Net income: 1551461
Capital expenditures: 3627029
Operating cash flow: 8348174
Depreciation & amortization: 3201654
Net tangible assets: 100190316
Owner earnings: 1126086
Return on net tangible assets (%): 1.1239469491243046
Capex to operating income (%): 103.66544595649401
Buffett classification: The Gruesome
Stock price: 7.04
P/E ratio: 38.24884686560114
Shares outstanding: 30248617
Book value: 100190316
P/B ratio: 2.125457551007225
Market cap (USD): 212950263.68
Debt to equity: 0.004165143066321899
Current ratio: 2.2332119699299713
Quick ratio: 2.2332119699299713
Effective tax rate (%): 54.222683695135174
Interest coverage ratio: 175.7652466592987
COGS to revenue (%): 54.00755441006688
SG&A to revenue (%): 15.894696248077267
Free cash flow (dilution-adjusted): 4335307
Buyback yield (%): 0
Retained earnings: -38688953
Receivables turnover: 2.1147863252683385
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0107344287252102
FCF margin (%): 37.29381999569367
Revenue growth (%): -28.07874583775182
Rule of 40 score: 9.215074157941846
Financial ratios for EPSN — quarterly report dated 2025-09-30
Total revenue: 8981459
Gross profit: 3450403
Operating income: 606005
Net income: 1072295
Capital expenditures: 40876
Operating cash flow: 3965950
Depreciation & amortization: 2570462
Net tangible assets: 100218033
Owner earnings: 3601881
Return on net tangible assets (%): 3.5940447963092628
Capex to operating income (%): 6.745158868326169
Buffett classification: The Great
Stock price: 4.87
P/E ratio: 22.186057810563288
Shares outstanding: 30248617
Book value: 100218033
P/B ratio: 1.4699027747830573
Market cap (USD): 147310764.79
Debt to equity: 0.0038621991313679046
Current ratio: 1.9281858077070109
Quick ratio: 1.9281858077070109
Effective tax rate (%): 34.964810600730715
Interest coverage ratio: 51.94625407166124
COGS to revenue (%): 61.58304569446902
SG&A to revenue (%): 31.669665251491992
Free cash flow (dilution-adjusted): 3630213
Buyback yield (%): 0
Retained earnings: -38995173
Receivables turnover: 1.9891612750622951
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5207643220672517
FCF margin (%): 40.4189675641786
Revenue growth (%): -22.738363109070978
Rule of 40 score: 17.680604455107623